Inactivating mutations in LDLR, LPL, and APOA5 are associated with increased risk while mutations in PCSK9, NPC1L1, ASGR1, APOC3, ANGPTL4, and LPA are associated with decreased risk of CAD [89,90,91]. This evidence concerns the gene NPC1L1 and coronary artery disorder.